Metabolic Bulk Volume is an independent prognostic factor and facilitates identifying high risk cases for DLBCL patients treated with the R-CHOP
Silu Cui, Panpan Luan, Yuxiao Hu, Qi Jiang
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsVenous Thromboembolism Diagnosis and Management · Lymphatic System and Diseases · Myeloproliferative Neoplasms: Diagnosis and Treatment
There was a mistake in Figure 4 as published. The label below “Panel B” of Figure 4 was incorrectly marked as “PFS”. The correct label should be “time months”. The corrected Figure 4 appears below.
There was a mistake in Figure 5 as published. “Panel A” of Figure 5 contains two subfigures, and the first subfigure of “Panel A” was incorrectly duplicated from the first subfigure of “Panel B”. The corrected Figure 5 appears below.
There was a mistake in the caption of Table 4 as published. The title of Table 4 was incorrectly stated as “Multivariate Cox regression analysis for OS and OS.” The correct title should be “Multivariate Cox regression analysis for PFS and OS”. The corrected caption of Table 4 appears below.
“Multivariate Cox regression analysis for PFS and OS.”
The original version of this article has been updated.